Dr. George Poste, Chief Scientist of the Complex Adaptive Systems Initiative, Regents Professor, and Del E. Webb Chair in Health Innovation at Arizona State University, has been selected to receive the 2025 Annual Award for Leadership in Personalized Medicine by the Personalized Medicine Coalition (PMC) (http://www.personalizedmedicinecoalition.org/) announced Thursday July 24, 2025.
With over 200 members, PMC serves as the leading voice in advancing a tailored approach to medicine. Through influential policy papers, congressional testimony, and multi-stakeholder engagement, PMC continues to shape the evolving landscape of technology innovation, regulation, and reimbursement in healthcare.
Dr. Poste joins a distinguished group of past recipients, including leaders:
- Dr. Francis S. Collins, M.D., Ph.D., (former Director, U.S. National Institutes of Health)
- Dr. Janet Woodcock, M.D., (former Director, U.S. Food and Drug Administration, Center for Drug Evaluation and Research)
- Dr. Carl H. June, M.D., (University of Pennsylvania and pioneer of CAR-T Cancer Immunotherapy)
- Dr. Leroy Hood, Ph.D., M.D., (President, Institute for Systems Biology and multiOmics pioneer)
- Dr. William S. Dalton, Ph.D., M.D., CEO, (Director Moffitt Cancer Center)
- Jay T. Flatley, (CEO, Illumina)
- Dr. Ellen V. Sigal, Ph.D., (Founder, Friends of Cancer Research and 21st Century Cures Act)
- Michael O. Leavitt, (U.S. Secretary, Department of Health and Human Services)
- Brook Byers, (Managing Partner, Kleiner Perkins Caufield & Byers and long-time leading venture capitalist in the growth of the biotechnology industry)
- Kathy Giusti, (CEO, Multiple Myeloma Research Foundation)
The award will be formally presented at the 19th Annual Personalized Medicine Conference, to be held November 13–14, 2025, at the Ritz-Carlton Laguna Niguel in Dana Point, California (https://www.personalizedmedicineconference.org/). Following the presentation, Dr. Poste will deliver the keynote address outlining his perspectives on the challenges and opportunities that define the next era of precision healthcare.
Please join us in congratulating Dr. Poste on this well-earned recognition.
